XML 57 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2023
STOCKHOLDERS' EQUITY  
Schedule of BSM using weighted-average assumptions

These fair values were derived using the BSM with the following weighted-average assumptions:

    

For the Years Ended December 31, 

 

2023

2022

 

Average risk-free interest rate

 

4.18

%  

2.79

%

Expected dividend yield

 

%  

%

Expected lives

 

5.59 years

 

5.69 years

Expected volatility

 

53.14

%  

79.92

%

Schedule of transaction and other information relating to stock options

Transactions and other information relating to stock options of Class D common stock for the years ended December 31, 2023 and 2022 are summarized below:

    

    

    

Weighted-Average

    

Remaining

Aggregate

Number of 

Weighted-Average

Contractual Term

Intrinsic

Options

Exercise Price

 (In Years)

Value

Outstanding at December 31, 2021

 

3,770,913

$

2.18

 

5.68

$

4,659,601

Grants

 

884,061

4.22

 

 

Exercised

 

(60,240)

0.83

 

 

315,620

Forfeited/cancelled/expired/settled

 

 

 

Outstanding at December 31, 2022

 

4,594,734

$

2.59

 

5.72

$

5,871,492

Grants

 

649,453

5.20

 

 

Exercised

 

 

 

Forfeited/cancelled/expired/settled

 

(20,051)

4.75

 

 

Outstanding at December 31, 2023(1)

 

5,224,136

2.90

 

5.28

$

5,021,952

Vested and expected to vest at December 31, 2023

 

5,171,594

2.89

 

5.24

5,021,952

Unvested at December 31, 2023

 

452,524

4.71

 

9.19

Exercisable at December 31, 2023

 

4,771,612

2.73

 

4.91

5,021,952

(1) The aggregate intrinsic value in the table above represents the difference between the Company’s stock closing price on the last day of trading during the year ended December 31, 2023, and the exercise price, multiplied by the number of shares that would have been received by the holders of in-the-money options had all the option holders exercised their options on December 31, 2023. This amount changes based on the fair market value of the Company’s stock.

Schedule of transaction and other information relating to restricted stock grants

Transactions and other information relating to grants of restricted shares of Class D common stock for the years ended December 31, 2023 and 2022 are summarized below:

    

    

Average

Fair Value

at Grant

Shares

Date

Unvested at December 31, 2021

 

76,056

$

3.90

Grants

 

1,357,687

4.27

Vested

 

(999,479)

4.25

Forfeited/cancelled/expired

 

Unvested at December 31, 2022

 

434,264

$

4.27

Grants

 

895,520

5.17

Vested

 

(1,001,667)

4.92

Forfeited/cancelled/expired

 

(15,000)

4.12

Unvested at December 31, 2023

 

313,117

$

4.77